Skip to main content
Premium Trial:

Request an Annual Quote

Canada Provides C$1.1M for Synthetic Biology to University of Lethbridge

NEW YORK (GenomeWeb) – The Canadian government today announced it is providing C$1.1 million (US$864,000) in funding to the University of Lethbridge to support the creation of Alberta's first synthetic biology maker space. 

With the funding provided through Western Economic Diversification Canada's Western Diversification Program, the synthetic biology maker space will "enhance research capabilities, boost services available for industry partners, increase training capacity … and enable students to explore commercial applications of their research ideas," WEDC said in a statement. 

The funding will go toward the purchase of a PCR cycler and a cell sorter, as well as the development of a protein and nucleic acid purification infrastructure for assembling biological devices.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.